| MolName | 2-[4-[(2R,4S)-5-[(3S,5R)-3,5-dibenzyl-2-oxopyrrolidin-1-yl]-4-hydroxy-2-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl]pentyl]phenoxy]ethyl morpholine-4-carboxylate |
| MolecularFormula | C46H53N3O8 |
| Smiles | O[C@@H](C[C@@H](Cc(cc1)ccc1OCCOC(N1CCOCC1)=O)C(N[C@H]([C@@H](C1)O)c2c1cccc2)=O)CN([C@@H](Cc1ccccc1)C[C@@H]1Cc2ccccc2)C1=O |
| InChI | InChI=1S/C46H53N3O8/c50-39(31-49-38(27-33-11-5-2-6-12-33)28-37(45(49)53)26-32-9-3-1-4-10-32)29-36(44(52)47-43-41-14-8-7-13-35(41)30-42(43)51)25-34-15-17-40(18-16-34)56-23-24-57-46(54)48-19-21-55-22-20-48/h1-18,36-39,42-43,50-51H,19-31H2,(H,47,52)/t36-,37+ |
| InChIK | FKLCRUVOWWCXRT-VPISVCLZSA-N |
| TotalMolweight | 775.94 |
| Molweight | 775.94 |
| MonoisotopicMass | 775.383267 |
| CLogP | 5.7631 |
| CLogS | -6.175 |
| H Acceptors | 11 |
| H Donors | 3 |
| TotalSurfaceArea | 593.93 |
| Relative PSA | 0.19174 |
| PolarSurfaceArea | 137.87 |
| Druglikeness | -6.4681 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | high |
| Nasty Functions | |
| Shape Index | 0.45614 |
| Fragments | 1 |
| Non HAtoms | 57 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| StereoCenters | 6 |
| Rotatable Bond | 17 |
| Rings Closures | 7 |
| Small Rings | 7 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 24 |
| Sp3Atoms | 24 |
| Symmetricatoms | 8 |
| Amides | 3 |
| StereoCon | this enantiomer |
Click to Load Molecule:
1 - 2-[4-[(2R,4S)-5-[(3S,5R)-3,5-dibenzyl-2-oxopyrrolidin-1-yl]-4-hydroxy-2-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl]pentyl]phenoxy]ethyl morpholine-4-carboxylate | 2 - 2-[4-[(2R,4S)-5-[(3S,5R)-3,5-dibenzyl-2-oxopyrrolidin-1-yl]-4-hydroxy-2-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl]pentyl]phenoxy]ethyl morpholine-4-carboxylate